Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Evaluation the clinical efficacy and safety profile of glucocorticosteroid combined with oral
T2 (chloroform/methanol extract of Tripterygium wilfordii Hook F) in the treatment of
patients with lupus nephritis. Open-labeled, randomized, prospective multi-center clinical
trial. Observation period of 24 weeks.